Search by property

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

List of results

• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.54  + (§ 11.54)
• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.6  + (§ 11.6)
• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.64  + (§ 11.64)
• Reference:USA 21 CFR Part 11 09-Apr-2025 § 11.70  + (§ 11.70)
• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.8  + (§ 11.8)
• Reference:DEU MBO - Berufsordnung der Ärzt:innen 11-Jun-2021 § 15  + (§ 15)
• Reference:USA 45 CFR Part 160 09-Apr-2025 § 164.508  + (§ 164.508)
• Reference:USA 45 CFR Part 160 09-Apr-2025 § 164.512  + (§ 164.512)
• Reference:USA 45 CFR Part 160 09-Apr-2025 § 164.526  + (§ 164.526)
• Reference:USA 45 CFR Part 160 09-Apr-2025 § 164.530  + (§ 164.530)
• Reference:DEU MPAMIV - Medizinprodukte-Anwendermelde- und Informationsverordnung 21-Apr-2021 § 2  + (§ 2)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 2 Absatz 1 – 2  + (§ 2 Absatz 1 – 2)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 2 Absatz 3  + (§ 2 Absatz 3)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 2 Absatz 3a–4  + (§ 2 Absatz 3a–4)
• Reference:DEU AMWHV – Arzneimittel- und Wirkstoffherstellungs-verordnung 09-Aug-2019 § 20  + (§ 20)
• Reference:AUT MPG – Medizinproduktegesetz 26-May-2022 § 22  + (§ 22)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 26  + (§ 26)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 28 Absatz 1 – 2  + (§ 28 Absatz 1 – 2)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 28 Absatz 3  + (§ 28 Absatz 3)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 28 Absatz 4 – 6  + (§ 28 Absatz 4 – 6)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 3  + (§ 3)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 3 Absatz 4  + (§ 3 Absatz 4)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 3 Absatz 5 – 6  + (§ 3 Absatz 5 – 6)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 30-001  + (§ 30)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 30-002  + (§ 30)

• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 31  + (§ 31)

• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.21  + (§ 312.21)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.23 (6) (c) - (d)  + (§ 312.23 (6) (c) - (d))
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.23 (6) (d)  + (§ 312.23 (6) (d))
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.23 (a) ; (5)  + (§ 312.23 (a) ; (5))
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.23 (a) ; (6)  + (§ 312.23 (a) ; (6))
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.3 (b) - CRO  + (§ 312.3 (b) - CRO)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.3 (b) - Sponsor  + (§ 312.3 (b) - Sponsor)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.3 (b) - Sponsor-Investigator  + (§ 312.3 (b) - Sponsor-Investigator)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.3 - Clinical investigation  + (§ 312.3 - Clinical investigation)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.3 - IEC  + (§ 312.3 - IEC)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.3 - Investigator  + (§ 312.3 - Investigator)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.30  + (§ 312.30)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.30 (b) (ii)  + (§ 312.30 (b) (ii))
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.31  + (§ 312.31)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.32 (b)  + (§ 312.32 (b))
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.32 (c)  + (§ 312.32 (c))
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.32 (d)  + (§ 312.32 (d))
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.32 - Adverse event  + (§ 312.32 - Adverse event)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.32 - Life-threatening Adverse event  + (§ 312.32 - Life-threatening Adverse event)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.32 - SAE  + (§ 312.32 - SAE)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.32 - Suspected adverse reaction  + (§ 312.32 - Suspected adverse reaction)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.32 - Unexpected adverse event  + (§ 312.32 - Unexpected adverse event)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.33  + (§ 312.33)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.33 (a) (3)  + (§ 312.33 (a) (3))
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.33 (a) - (b)  + (§ 312.33 (a) - (b))